A form of invasive candidiasis where species of CANDIDA are present in the blood.
The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis (CANDIDIASIS, VULVOVAGINAL), and thrush (see CANDIDIASIS, ORAL). (From Dorland, 28th ed)
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
An important nosocomial fungal infection with species of the genus CANDIDA, most frequently CANDIDA ALBICANS. Invasive candidiasis occurs when candidiasis goes beyond a superficial infection and manifests as CANDIDEMIA, deep tissue infection, or disseminated disease with deep organ involvement.
The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.
A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.
Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
A species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.
Any infection which a patient contracts in a health-care institution.
A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).
Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein.
Substances of fungal origin that have antigenic activity.
The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
Care of a highly technical and specialized nature, provided in a medical center, usually one affiliated with a university, for patients with unusually severe, complex, or uncommon health problems.
Glucose polymers consisting of a backbone of beta(1->3)-linked beta-D-glucopyranosyl units with beta(1->6) linked side chains of various lengths. They are a major component of the CELL WALL of organisms and of soluble DIETARY FIBER.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
A decrease in the number of NEUTROPHILS found in the blood.
Polysaccharides consisting of mannose units.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Compounds consisting of a short peptide chain conjugated with an acyl chain.
Immunoglobulins produced in a response to FUNGAL ANTIGENS.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Hospital units providing continuous surveillance and care to acutely ill patients.
I'm sorry for any confusion, but "Kuwait" is not a medical term that has a definition in the field of medicine. Kuwait is actually a country located in the Middle East, known officially as the State of Kuwait. It might be that you have confused it with a medical condition or term, if so, I would be happy to help clarify or provide information on that topic instead.
Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses.
Hospital units providing continuing surveillance and care to acutely ill newborn infants.
Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed)
Catheters designed to be left within an organ or passage for an extended period of time.
Mycoses are a group of diseases caused by fungal pathogens that can infect various tissues and organs, potentially leading to localized or systemic symptoms, depending on the immune status of the host.
An infant during the first month after birth.
Procedures for identifying types and strains of fungi.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.
A medical facility which provides a high degree of subspecialty expertise for patients from centers where they received SECONDARY CARE.
Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.
The ability of fungi to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutations.
Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
Triazoles are a class of antifungal drugs that contain a triazole ring in their chemical structure and work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting the integrity and function of the membrane.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Institutions with an organized medical staff which provide medical care to patients.
I'm sorry for any confusion, but "Iceland" is a country located in Northern Europe, and it doesn't have a medical definition. If you're referring to a term in medicine that might be associated with Iceland, perhaps you're thinking of "Iceland syndrome," which is a medical condition named after the place where it was first described, not because it's unique to Iceland. It refers to a rare occurrence of unilateral lower limb edema (swelling) due to a deep vein thrombosis (blood clot) in the iliofemoral vein, often associated with malignancy.
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
Deoxyribonucleic acid that makes up the genetic material of fungi.
A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent.
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.

Incidence and predictors of invasive candidiasis associated with candidaemia in children. (1/130)

 (+info)

Comparison of albicans vs. non-albicans candidemia in French intensive care units. (2/130)

 (+info)

Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. (3/130)

 (+info)

Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expression. (4/130)

 (+info)

Analysis of Candida glabrata strains with reduced sensitivity to micafungin in vitro isolated from a patient with persistent Candidemia. (5/130)

We report the appearance of Candida glabrata strains with reduced sensitivity during treatment with the echinocandin drug micafungin (MCF). Four C. glabrata strains were isolated from sputum, gastric juice, and blood taken from a patient during hospitalization. Two of these strains, one of which was obtained after treatment with MCF for suspected Candida pneumonia and the other of which was obtained during MCF treatment for candidemia, were isolated from blood and found to have a reduced susceptibility to MCF. These two clinical isolates showed a high minimum inhibitory concentration (MIC) for MCF, with this change in MIC being unique for MCF among established antifungal drugs. To further investigate the mechanism underlying this reduced sensitivity, an in vivo mouse infection model and in vitro enzymatic analysis were performed. MCF had little effect in the mouse disseminated infection model and enzymatic analysis showed the low affinity of MCF to the 1,3-Beta-D-glucan synthase of the clinical isolates, although the enzymes of both clinical isolates and control strain were noncompetitively inhibited by MCF. Taken together, this low affinity of MCF for the enzymes is likely to cause the reduced sensitivities. These data further indicate that MCF could induce acquired MCF-resistant strains during clinical use.  (+info)

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. (6/130)

 (+info)

Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. (7/130)

 (+info)

Candidemia after cardiac surgery in the intensive care unit: an observational study. (8/130)

 (+info)

Candidemia is a medical condition defined as the presence of the fungus Candida in the bloodstream. It is a type of invasive candidiasis, which occurs when Candida invades normally sterile areas of the body such as the blood, heart, brain, eyes, or bones. Candidemia is usually acquired in healthcare settings and can cause serious illness, especially in people with weakened immune systems. Symptoms may include fever, chills, hypotension, and organ dysfunction. Treatment typically involves antifungal medications.

Fungemia is the presence of fungi (fungal organisms) in the blood. It's a type of bloodstream infection, which can be serious and life-threatening, particularly for people with weakened immune systems. The fungi that cause fungemia often enter the bloodstream through medical devices like catheters or from a fungal infection somewhere else in the body.

Fungemia is often associated with conditions like candidemia (caused by Candida species) and aspergillemia (caused by Aspergillus species). Symptoms can vary widely but often include fever, chills, and other signs of infection. It's important to diagnose and treat fungemia promptly to prevent serious complications like sepsis.

Candidiasis is a fungal infection caused by Candida species, most commonly Candida albicans. It can affect various parts of the body, including the skin, mucous membranes (such as the mouth and vagina), and internal organs (like the esophagus, lungs, or blood).

The symptoms of candidiasis depend on the location of the infection:

1. Oral thrush: White patches on the tongue, inner cheeks, gums, or roof of the mouth. These patches may be painful and can bleed slightly when scraped.
2. Vaginal yeast infection: Itching, burning, redness, and swelling of the vagina and vulva; thick, white, odorless discharge from the vagina.
3. Esophageal candidiasis: Difficulty swallowing, pain when swallowing, or feeling like food is "stuck" in the throat.
4. Invasive candidiasis: Fever, chills, and other signs of infection; multiple organ involvement may lead to various symptoms depending on the affected organs.

Risk factors for developing candidiasis include diabetes, HIV/AIDS, use of antibiotics or corticosteroids, pregnancy, poor oral hygiene, and wearing tight-fitting clothing that traps moisture. Treatment typically involves antifungal medications, such as fluconazole, nystatin, or clotrimazole, depending on the severity and location of the infection.

'Candida' is a type of fungus (a form of yeast) that is commonly found on the skin and inside the body, including in the mouth, throat, gut, and vagina, in small amounts. It is a part of the normal microbiota and usually does not cause any problems. However, an overgrowth of Candida can lead to infections known as candidiasis or thrush. Common sites for these infections include the skin, mouth, throat, and genital areas. Some factors that can contribute to Candida overgrowth are a weakened immune system, certain medications (such as antibiotics and corticosteroids), diabetes, pregnancy, poor oral hygiene, and wearing damp or tight-fitting clothing. Common symptoms of candidiasis include itching, redness, pain, and discharge. Treatment typically involves antifungal medication, either topical or oral, depending on the site and severity of the infection.

Antifungal agents are a type of medication used to treat and prevent fungal infections. These agents work by targeting and disrupting the growth of fungi, which include yeasts, molds, and other types of fungi that can cause illness in humans.

There are several different classes of antifungal agents, including:

1. Azoles: These agents work by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Examples of azole antifungals include fluconazole, itraconazole, and voriconazole.
2. Echinocandins: These agents target the fungal cell wall, disrupting its synthesis and leading to fungal cell death. Examples of echinocandins include caspofungin, micafungin, and anidulafungin.
3. Polyenes: These agents bind to ergosterol in the fungal cell membrane, creating pores that lead to fungal cell death. Examples of polyene antifungals include amphotericin B and nystatin.
4. Allylamines: These agents inhibit squalene epoxidase, a key enzyme in ergosterol synthesis. Examples of allylamine antifungals include terbinafine and naftifine.
5. Griseofulvin: This agent disrupts fungal cell division by binding to tubulin, a protein involved in fungal cell mitosis.

Antifungal agents can be administered topically, orally, or intravenously, depending on the severity and location of the infection. It is important to use antifungal agents only as directed by a healthcare professional, as misuse or overuse can lead to resistance and make treatment more difficult.

Fluconazole is an antifungal medication used to treat and prevent various fungal infections, such as candidiasis (yeast infections), cryptococcal meningitis, and other fungal infections that affect the mouth, throat, blood, lungs, genital area, and other parts of the body. It works by inhibiting the growth of fungi that cause these infections. Fluconazole is available in various forms, including tablets, capsules, and intravenous (IV) solutions, and is typically prescribed to be taken once daily.

The medical definition of Fluconazole can be found in pharmacological or medical dictionaries, which describe it as a triazole antifungal agent that inhibits fungal cytochrome P450-dependent synthesis of ergosterol, a key component of the fungal cell membrane. This results in increased permeability and leakage of cellular contents, ultimately leading to fungal death. Fluconazole has a broad spectrum of activity against various fungi, including Candida, Cryptococcus, Aspergillus, and others.

It is important to note that while Fluconazole is an effective antifungal medication, it may have side effects and interactions with other medications. Therefore, it should only be used under the guidance of a healthcare professional.

Invasive candidiasis is a serious and potentially life-threatening fungal infection caused by the Candida species, most commonly Candida albicans. It occurs when the fungus invades normally sterile areas of the body, such as the bloodstream, heart, brain, or eyes. Invasive candidiasis can cause a variety of symptoms depending on the site of infection, and may include fever, chills, hypotension, sepsis, organ dysfunction, and skin lesions.

Risk factors for invasive candidiasis include prolonged use of broad-spectrum antibiotics, immunosuppression, indwelling catheters, recent surgery, critical illness, and underlying medical conditions such as diabetes or cancer. Diagnosis typically involves blood cultures and sometimes tissue biopsy, and treatment usually requires intravenous antifungal medications such as echinocandins, fluconazole, or amphotericin B. Prompt diagnosis and treatment are essential to prevent serious complications and improve outcomes.

Fungal drug resistance is a condition where fungi are no longer susceptible to the antifungal drugs that were previously used to treat infections they caused. This can occur due to genetic changes in the fungi that make them less sensitive to the drug's effects, or due to environmental factors that allow the fungi to survive and multiply despite the presence of the drug.

There are several mechanisms by which fungi can develop drug resistance, including:

1. Mutations in genes that encode drug targets: Fungi can acquire mutations in the genes that encode for the proteins or enzymes that the antifungal drugs target. These mutations can alter the structure or function of these targets, making them less susceptible to the drug's effects.
2. Overexpression of efflux pumps: Fungi can increase the expression of genes that encode for efflux pumps, which are proteins that help fungi expel drugs from their cells. This can reduce the intracellular concentration of the drug and make it less effective.
3. Changes in membrane composition: Fungi can alter the composition of their cell membranes to make them less permeable to antifungal drugs, making it more difficult for the drugs to enter the fungal cells and exert their effects.
4. Biofilm formation: Fungi can form biofilms, which are complex communities of microorganisms that adhere to surfaces and are protected by a matrix of extracellular material. Biofilms can make fungi more resistant to antifungal drugs by limiting drug penetration and creating an environment that promotes the development of resistance.

Fungal drug resistance is a significant clinical problem, particularly in patients with weakened immune systems, such as those with HIV/AIDS or cancer. It can lead to treatment failures, increased morbidity and mortality, and higher healthcare costs. To address this issue, there is a need for new antifungal drugs, as well as strategies to prevent and manage drug resistance.

'Candida glabrata' is a species of yeast that is commonly found on the skin and mucous membranes of humans. It is a member of the genus Candida, which includes several species of fungi that can cause infections in humans. C. glabrata is one of the more common causes of candidiasis, or yeast infections, particularly in the mouth (oral thrush) and genital area. It can also cause invasive candidiasis, a serious systemic infection that can affect various organs and tissues in the body. C. glabrata is often resistant to some of the antifungal drugs commonly used to treat Candida infections, making it more difficult to treat.

Echinocandins are a class of antifungal medications that inhibit the synthesis of 1,3-β-D-glucan, a key component of the fungal cell wall. This results in osmotic instability and ultimately leads to fungal cell death. Echinocandins are commonly used to treat invasive fungal infections caused by Candida species and Aspergillus species. The three drugs in this class that are approved for use in humans are caspofungin, micafungin, and anidulafungin.

Here's a brief overview of each drug:

1. Caspofungin (Cancidas, Cancidas-W): This is the first echinocandin to be approved for use in humans. It is indicated for the treatment of invasive candidiasis, including candidemia, acute disseminated candidiasis, and other forms of Candida infections. Caspofungin is also approved for the prevention of Candida infections in patients undergoing hematopoietic stem cell transplantation.
2. Micafungin (Mycamine): This echinocandin is approved for the treatment of candidemia, esophageal candidiasis, and other forms of Candida infections. It is also used for the prevention of Candida infections in patients undergoing hematopoietic stem cell transplantation.
3. Anidulafungin (Eraxis): This echinocandin is approved for the treatment of esophageal candidiasis and candidemia, as well as other forms of Candida infections. It is also used for the prevention of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Echinocandins have a broad spectrum of activity against many fungal species, including those that are resistant to other classes of antifungal medications. They are generally well-tolerated and have a low incidence of drug interactions. However, they should be used with caution in patients with hepatic impairment, as their metabolism may be affected by liver dysfunction.

Amphotericin B is an antifungal medication used to treat serious and often life-threatening fungal infections. It works by binding to the ergosterol in the fungal cell membrane, creating pores that lead to the loss of essential cell components and ultimately cell death.

The medical definition of Amphotericin B is:

A polyene antifungal agent derived from Streptomyces nodosus, with a broad spectrum of activity against various fungi, including Candida, Aspergillus, Cryptococcus, and Histoplasma capsulatum. Amphotericin B is used to treat systemic fungal infections, such as histoplasmosis, cryptococcosis, candidiasis, and aspergillosis, among others. It may be administered intravenously or topically, depending on the formulation and the site of infection.

Adverse effects associated with Amphotericin B include infusion-related reactions (such as fever, chills, and hypotension), nephrotoxicity, electrolyte imbalances, and anemia. These side effects are often dose-dependent and may be managed through careful monitoring and adjustment of the dosing regimen.

'Candida tropicalis' is a species of yeast that can be found normally in certain environments, including the human body (such as the skin, mouth, and digestive system). However, it can also cause infections in people with weakened immune systems or underlying medical conditions. These infections can occur in various parts of the body, including the bloodstream, urinary tract, and skin.

Like other Candida species, C. tropicalis is a type of fungus that reproduces by budding, forming oval-shaped cells. It is often resistant to certain antifungal medications, which can make infections more difficult to treat. Proper diagnosis and treatment, usually with antifungal drugs, are essential for managing C. tropicalis infections.

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

'Candida albicans' is a species of yeast that is commonly found in the human body, particularly in warm and moist areas such as the mouth, gut, and genital region. It is a part of the normal microbiota and usually does not cause any harm. However, under certain conditions like a weakened immune system, prolonged use of antibiotics or steroids, poor oral hygiene, or diabetes, it can overgrow and cause infections known as candidiasis. These infections can affect various parts of the body including the skin, nails, mouth (thrush), and genital area (yeast infection).

The medical definition of 'Candida albicans' is:

A species of yeast belonging to the genus Candida, which is commonly found as a commensal organism in humans. It can cause opportunistic infections when there is a disruption in the normal microbiota or when the immune system is compromised. The overgrowth of C. albicans can lead to various forms of candidiasis, such as oral thrush, vaginal yeast infection, and invasive candidiasis.

Central venous catheterization is a medical procedure in which a flexible tube called a catheter is inserted into a large vein in the body, usually in the neck (internal jugular vein), chest (subclavian vein), or groin (femoral vein). The catheter is threaded through the vein until it reaches a central location, such as the superior vena cava or the right atrium of the heart.

Central venous catheterization may be performed for several reasons, including:

1. To administer medications, fluids, or nutritional support directly into the bloodstream.
2. To monitor central venous pressure (CVP), which can help assess a patient's volume status and cardiac function.
3. To draw blood samples for laboratory tests.
4. To deliver chemotherapy drugs or other medications that may be harmful to peripheral veins.
5. To provide access for hemodialysis or other long-term therapies.

The procedure requires careful attention to sterile technique to minimize the risk of infection, and it is usually performed under local anesthesia with sedation or general anesthesia. Complications of central venous catheterization may include bleeding, infection, pneumothorax (collapsed lung), arterial puncture, and catheter-related bloodstream infections (CRBSI).

Fungal antigens are substances found on or produced by fungi that can stimulate an immune response in a host organism. They can be proteins, polysaccharides, or other molecules that are recognized as foreign by the host's immune system. Fungal antigens can be used in diagnostic tests to identify fungal infections, and they can also be targets of immune responses during fungal infections. In some cases, fungal antigens may contribute to the pathogenesis of fungal diseases by inducing inflammatory or allergic reactions. Examples of fungal antigens include the cell wall components of Candida albicans and the extracellular polysaccharide galactomannan produced by Aspergillus fumigatus.

Mycology is the branch of biology that deals with the study of fungi, including their genetic and biochemical properties, their taxonomy and classification, their role in diseases and decomposition processes, and their potential uses in industry, agriculture, and medicine. It involves the examination and identification of various types of fungi, such as yeasts, molds, and mushrooms, and the investigation of their ecological relationships with other organisms and their environments. Mycologists may also study the medical and veterinary importance of fungi, including the diagnosis and treatment of fungal infections, as well as the development of antifungal drugs and vaccines.

Tertiary healthcare is a level of health services delivery that involves highly specialized care, often provided by tertiary care hospitals or centers. These facilities typically have advanced diagnostic and treatment capabilities, including access to specialized medical professionals such as surgeons, oncologists, neurologists, and other specialists who provide complex medical and surgical interventions.

Tertiary healthcare services are designed to address the needs of patients with more severe or complicated medical conditions that cannot be managed at primary or secondary care levels. These services often involve highly specialized procedures, such as organ transplants, cancer treatments, advanced neurosurgical procedures, and other complex interventions. Tertiary care facilities may also serve as referral centers for smaller hospitals and clinics, providing consultation, diagnosis, and treatment recommendations for patients with rare or difficult-to-diagnose conditions.

It's important to note that tertiary healthcare is not always accessible to everyone due to factors such as cost, location, and availability of specialized services. Access to tertiary care can vary widely depending on the healthcare system and resources available in a given region or country.

Beta-glucans are a type of complex carbohydrate known as polysaccharides, which are found in the cell walls of certain cereals, bacteria, and fungi, including baker's yeast, mushrooms, and algae. They consist of long chains of glucose molecules linked together by beta-glycosidic bonds.

Beta-glucans have been studied for their potential health benefits, such as boosting the immune system, reducing cholesterol levels, and improving gut health. They are believed to work by interacting with immune cells, such as macrophages and neutrophils, and enhancing their ability to recognize and destroy foreign invaders like bacteria, viruses, and tumor cells.

Beta-glucans are available in supplement form and are also found in various functional foods and beverages, such as baked goods, cereals, and sports drinks. However, it is important to note that the effectiveness of beta-glucans for these health benefits may vary depending on the source, dose, and individual's health status. Therefore, it is recommended to consult with a healthcare professional before taking any dietary supplements or making significant changes to your diet.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

Neutropenia is a condition characterized by an abnormally low concentration (less than 1500 cells/mm3) of neutrophils, a type of white blood cell that plays a crucial role in fighting off bacterial and fungal infections. Neutrophils are essential components of the innate immune system, and their main function is to engulf and destroy microorganisms that can cause harm to the body.

Neutropenia can be classified as mild, moderate, or severe based on the severity of the neutrophil count reduction:

* Mild neutropenia: Neutrophil count between 1000-1500 cells/mm3
* Moderate neutropenia: Neutrophil count between 500-1000 cells/mm3
* Severe neutropenia: Neutrophil count below 500 cells/mm3

Severe neutropenia significantly increases the risk of developing infections, as the body's ability to fight off microorganisms is severely compromised. Common causes of neutropenia include viral infections, certain medications (such as chemotherapy or antibiotics), autoimmune disorders, and congenital conditions affecting bone marrow function. Treatment for neutropenia typically involves addressing the underlying cause, administering granulocyte-colony stimulating factors to boost neutrophil production, and providing appropriate antimicrobial therapy to prevent or treat infections.

Mannans are a type of complex carbohydrate, specifically a heteropolysaccharide, that are found in the cell walls of certain plants, algae, and fungi. They consist of chains of mannose sugars linked together, often with other sugar molecules such as glucose or galactose.

Mannans have various biological functions, including serving as a source of energy for microorganisms that can break them down. In some cases, mannans can also play a role in the immune response and are used as a component of vaccines to stimulate an immune response.

In the context of medicine, mannans may be relevant in certain conditions such as gut dysbiosis or allergic reactions to foods containing mannans. Additionally, some research has explored the potential use of mannans as a delivery vehicle for drugs or other therapeutic agents.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Lipopeptides are a type of molecule that consists of a lipid (fatty acid) tail attached to a small peptide (short chain of amino acids). They are produced naturally by various organisms, including bacteria, and play important roles in cell-to-cell communication, signaling, and as components of bacterial membranes. Some lipopeptides have also been found to have antimicrobial properties and are being studied for their potential use as therapeutic agents.

Fungal antibodies are a type of protein called immunoglobulins that are produced by the immune system in response to the presence of fungi in the body. These antibodies are specifically designed to recognize and bind to antigens on the surface of fungal cells, marking them for destruction by other immune cells.

There are several types of fungal antibodies, including IgA, IgG, IgM, and IgE, each with a specific role in the immune response. For example, IgG antibodies are the most common type of antibody found in the blood and provide long-term immunity to fungi, while IgE antibodies are associated with allergic reactions to fungi.

Fungal antibodies can be measured in the blood or other bodily fluids to help diagnose fungal infections, monitor the effectiveness of treatment, or assess immune function in individuals who are at risk for fungal infections, such as those with weakened immune systems due to HIV/AIDS, cancer, or organ transplantation.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

An Intensive Care Unit (ICU) is a specialized hospital department that provides continuous monitoring and advanced life support for critically ill patients. The ICU is equipped with sophisticated technology and staffed by highly trained healthcare professionals, including intensivists, nurses, respiratory therapists, and other specialists.

Patients in the ICU may require mechanical ventilation, invasive monitoring, vasoactive medications, and other advanced interventions due to conditions such as severe infections, trauma, cardiac arrest, respiratory failure, or post-surgical complications. The goal of the ICU is to stabilize patients' condition, prevent further complications, and support organ function while the underlying illness is treated.

ICUs may be organized into different units based on the type of care provided, such as medical, surgical, cardiac, neurological, or pediatric ICUs. The length of stay in the ICU can vary widely depending on the patient's condition and response to treatment.

I'm sorry for any confusion, but "Kuwait" is not a medical term or concept. It is the name of a country located in the Middle East, known officially as the State of Kuwait. If you have any questions about medical terminology or health-related topics, I would be happy to try and help answer those for you!

Fungal eye infections, also known as fungal keratitis or ocular fungal infections, are caused by the invasion of fungi into the eye. The most common types of fungi that cause these infections include Fusarium, Aspergillus, and Candida. These infections can affect any part of the eye, including the cornea, conjunctiva, sclera, and vitreous humor.

Fungal eye infections often present with symptoms such as redness, pain, sensitivity to light, tearing, blurred vision, and discharge. In severe cases, they can lead to corneal ulcers, perforation of the eye, and even blindness if left untreated. Risk factors for fungal eye infections include trauma to the eye, contact lens wear, immunosuppression, and pre-existing eye conditions such as dry eye or previous eye surgery.

Diagnosis of fungal eye infections typically involves a thorough eye examination, including visual acuity testing, slit lamp examination, and sometimes corneal scrapings for microbiological culture and sensitivity testing. Treatment usually involves topical antifungal medications, such as natamycin or amphotericin B, and in some cases may require oral or intravenous antifungal therapy. In severe cases, surgical intervention may be necessary to remove infected tissue or repair any damage caused by the infection.

A Neonatal Intensive Care Unit (NICU) is a specialized hospital unit that provides advanced, intensive care for newborn babies who are born prematurely, critically ill, or have complex medical conditions. The NICU staff includes neonatologists, neonatal nurses, respiratory therapists, and other healthcare professionals trained to provide specialized care for these vulnerable infants.

The NICU is equipped with advanced technology and monitoring systems to support the babies' breathing, heart function, temperature regulation, and nutrition. The unit may include incubators or radiant warmers to maintain the baby's body temperature, ventilators to assist with breathing, and intravenous lines to provide fluids and medications.

NICUs are typically classified into levels based on the complexity of care provided, ranging from Level I (basic care for healthy newborns) to Level IV (the highest level of care for critically ill newborns). The specific services and level of care provided in a NICU may vary depending on the hospital and geographic location.

Cutaneous candidiasis is a fungal infection of the skin caused by Candida species, most commonly Candida albicans. The infection can occur anywhere on the skin, but it typically affects warm, moist areas such as the armpits, groin, and fingers. The symptoms of cutaneous candidiasis include redness, itching, burning, and cracking of the skin. In severe cases, pustules or blisters may also be present.

The infection can occur in people of all ages but is more common in those with weakened immune systems, such as individuals with HIV/AIDS, diabetes, or cancer. Other risk factors include obesity, poor hygiene, and the use of certain medications, such as antibiotics and corticosteroids.

Treatment for cutaneous candidiasis typically involves topical antifungal medications, such as clotrimazole or miconazole. In severe cases, oral antifungal medications may be necessary. Keeping the affected area clean and dry is also important to prevent the spread of the infection.

Indwelling catheters, also known as Foley catheters, are medical devices that are inserted into the bladder to drain urine. They have a small balloon at the tip that is inflated with water once the catheter is in the correct position in the bladder, allowing it to remain in place and continuously drain urine. Indwelling catheters are typically used for patients who are unable to empty their bladders on their own, such as those who are bedridden or have nerve damage that affects bladder function. They are also used during and after certain surgical procedures. Prolonged use of indwelling catheters can increase the risk of urinary tract infections and other complications.

Mycoses are a group of diseases caused by fungal infections. These infections can affect various parts of the body, including the skin, nails, hair, lungs, and internal organs. The severity of mycoses can range from superficial, mild infections to systemic, life-threatening conditions, depending on the type of fungus and the immune status of the infected individual. Some common types of mycoses include candidiasis, dermatophytosis, histoplasmosis, coccidioidomycosis, and aspergillosis. Treatment typically involves antifungal medications, which can be topical or systemic, depending on the location and severity of the infection.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Mycological typing techniques are methods used to identify and classify fungi at the species or strain level, based on their unique biological characteristics. These techniques are often used in clinical laboratories to help diagnose fungal infections and determine the most effective treatment approaches.

There are several different mycological typing techniques that may be used, depending on the specific type of fungus being identified and the resources available in the laboratory. Some common methods include:

1. Phenotypic methods: These methods involve observing and measuring the physical characteristics of fungi, such as their growth patterns, colonial morphology, and microscopic features. Examples include macroscopic and microscopic examination, as well as biochemical tests to identify specific metabolic properties.

2. Genotypic methods: These methods involve analyzing the DNA or RNA of fungi to identify unique genetic sequences that can be used to distinguish between different species or strains. Examples include PCR-based methods, such as restriction fragment length polymorphism (RFLP) analysis and amplified fragment length polymorphism (AFLP) analysis, as well as sequencing-based methods, such as internal transcribed spacer (ITS) sequencing and multilocus sequence typing (MLST).

3. Proteotypic methods: These methods involve analyzing the proteins expressed by fungi to identify unique protein profiles that can be used to distinguish between different species or strains. Examples include matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and liquid chromatography-mass spectrometry (LC-MS).

Mycological typing techniques are important tools for understanding the epidemiology of fungal infections, tracking outbreaks, and developing effective treatment strategies. By accurately identifying the specific fungi causing an infection, healthcare providers can tailor their treatments to target the most vulnerable aspects of the pathogen, improving patient outcomes and reducing the risk of drug resistance.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

"APACHE" stands for "Acute Physiology And Chronic Health Evaluation." It is a system used to assess the severity of illness in critically ill patients and predict their risk of mortality. The APACHE score is calculated based on various physiological parameters, such as heart rate, blood pressure, temperature, respiratory rate, and laboratory values, as well as age and chronic health conditions.

There are different versions of the APACHE system, including APACHE II, III, and IV, each with its own set of variables and scoring system. The most commonly used version is APACHE II, which includes 12 physiological variables measured during the first 24 hours of ICU admission, as well as age and chronic health points.

The APACHE score is widely used in research and clinical settings to compare the severity of illness and outcomes between different patient populations, evaluate the effectiveness of treatments and interventions, and make informed decisions about resource allocation and triage.

Tertiary care centers are specialized healthcare facilities that provide complex medical and surgical services to patients with severe or rare conditions. These centers have advanced medical technology, specialized treatment options, and multidisciplinary teams of healthcare professionals who work together to manage the most challenging cases. Tertiary care centers often serve as referral centers for primary and secondary care providers, and they typically offer a wide range of services including cancer care, neurosurgery, cardiac surgery, transplantation, and other highly specialized treatments. Access to tertiary care centers is usually limited to patients who require advanced medical care that cannot be provided by community hospitals or smaller healthcare facilities.

Catheter-related infections are infections that occur due to the presence of a catheter, a flexible tube that is inserted into the body to perform various medical functions such as draining urine or administering medication. These infections can affect any part of the body where a catheter is inserted, including the bladder, bloodstream, heart, and lungs.

The most common type of catheter-related infection is a catheter-associated urinary tract infection (CAUTI), which occurs when bacteria enter the urinary tract through the catheter and cause an infection. Symptoms of CAUTI may include fever, chills, pain or burning during urination, and cloudy or foul-smelling urine.

Other types of catheter-related infections include catheter-associated bloodstream infections (CLABSI), which can occur when bacteria enter the bloodstream through the catheter, and catheter-related pulmonary infections, which can occur when secretions from the respiratory tract enter the lungs through a catheter.

Catheter-related infections are a significant concern in healthcare settings, as they can lead to serious complications such as sepsis, organ failure, and even death. Proper catheter insertion and maintenance techniques, as well as regular monitoring for signs of infection, can help prevent these types of infections.

Multiple drug resistance in fungi refers to the ability of certain fungal strains or species to resist the effects of multiple antifungal agents. This occurs when these organisms develop mechanisms that prevent the drugs from interfering with their growth and survival. As a result, the drugs become less effective or even completely ineffective at treating fungal infections caused by these resistant strains or species.

Multiple drug resistance in fungi can arise due to various factors, including genetic mutations, overuse or misuse of antifungal agents, and the ability of fungi to exchange genetic material with other fungi. This makes treatment of fungal infections more challenging, as doctors may need to use higher doses of drugs or try alternative therapies that may have more side effects or be less effective.

Multiple drug resistance in fungi is a significant concern in healthcare settings, particularly for patients who are immunocompromised or have underlying medical conditions that make them more susceptible to fungal infections. It is essential to take measures to prevent the development and spread of multiple drug-resistant fungi, such as using antifungal agents appropriately, practicing good infection control practices, and conducting surveillance for resistant strains.

Endophthalmitis is a serious inflammatory eye condition that occurs when an infection develops inside the eyeball, specifically within the vitreous humor (the clear, gel-like substance that fills the space between the lens and the retina). This condition can be caused by bacteria, fungi, or other microorganisms that enter the eye through various means, such as trauma, surgery, or spread from another infected part of the body.

Endophthalmitis is often characterized by symptoms like sudden onset of pain, redness, decreased vision, and increased sensitivity to light (photophobia). If left untreated, it can lead to severe complications, including blindness. Treatment typically involves administering antibiotics or antifungal medications, either systemically or directly into the eye, and sometimes even requiring surgical intervention to remove infected tissues and relieve intraocular pressure.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Itraconazole is an antifungal medication used to treat various fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thereby disrupting the integrity and function of these membranes. Itraconazole is available in oral and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Medical Definition:
Itraconazole (i-tra-KON-a-zole): A synthetic triazole antifungal agent used to treat various fungal infections, such as blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes, leading to disruption of their integrity and function. Itraconazole is available in oral (capsule and solution) and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Triazoles are a class of antifungal medications that have broad-spectrum activity against various fungi, including yeasts, molds, and dermatophytes. They work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased permeability and disruption of fungal growth. Triazoles are commonly used in both systemic and topical formulations for the treatment of various fungal infections, such as candidiasis, aspergillosis, cryptococcosis, and dermatophytoses. Some examples of triazole antifungals include fluconazole, itraconazole, voriconazole, and posaconazole.

Opportunistic infections (OIs) are infections that occur more frequently or are more severe in individuals with weakened immune systems, often due to a underlying condition such as HIV/AIDS, cancer, or organ transplantation. These infections are caused by microorganisms that do not normally cause disease in people with healthy immune function, but can take advantage of an opportunity to infect and cause damage when the body's defense mechanisms are compromised. Examples of opportunistic infections include Pneumocystis pneumonia, tuberculosis, candidiasis (thrush), and cytomegalovirus infection. Preventive measures, such as antimicrobial medications and vaccinations, play a crucial role in reducing the risk of opportunistic infections in individuals with weakened immune systems.

A hospital is a healthcare facility where patients receive medical treatment, diagnosis, and care for various health conditions, injuries, or diseases. It is typically staffed with medical professionals such as doctors, nurses, and other healthcare workers who provide round-the-clock medical services. Hospitals may offer inpatient (overnight) stays or outpatient (same-day) services, depending on the nature of the treatment required. They are equipped with various medical facilities like operating rooms, diagnostic equipment, intensive care units (ICUs), and emergency departments to handle a wide range of medical situations. Hospitals may specialize in specific areas of medicine, such as pediatrics, geriatrics, oncology, or trauma care.

I'm not aware of a medical definition for the term "Iceland." Iceland is actually a country in Northern Europe, located between the North Atlantic and Arctic Oceans. It is known for its dramatic landscape with volcanoes, geysers, hot springs, and lava fields.

If you have any medical or health-related question, I would be happy to help answer that for you.

Hematologic neoplasms, also known as hematological malignancies, are a group of diseases characterized by the uncontrolled growth and accumulation of abnormal blood cells or bone marrow cells. These disorders can originate from the myeloid or lymphoid cell lines, which give rise to various types of blood cells, including red blood cells, white blood cells, and platelets.

Hematologic neoplasms can be broadly classified into three categories:

1. Leukemias: These are cancers that primarily affect the bone marrow and blood-forming tissues. They result in an overproduction of abnormal white blood cells, which interfere with the normal functioning of the blood and immune system. There are several types of leukemia, including acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML).
2. Lymphomas: These are cancers that develop from the lymphatic system, which is a part of the immune system responsible for fighting infections. Lymphomas can affect lymph nodes, spleen, bone marrow, and other organs. The two main types of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
3. Myelomas: These are cancers that arise from the plasma cells, a type of white blood cell responsible for producing antibodies. Multiple myeloma is the most common type of myeloma, characterized by an excessive proliferation of malignant plasma cells in the bone marrow, leading to the production of abnormal amounts of monoclonal immunoglobulins (M proteins) and bone destruction.

Hematologic neoplasms can have various symptoms, such as fatigue, weakness, frequent infections, easy bruising or bleeding, weight loss, swollen lymph nodes, and bone pain. The diagnosis typically involves a combination of medical history, physical examination, laboratory tests, imaging studies, and sometimes bone marrow biopsy. Treatment options depend on the type and stage of the disease and may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell transplantation, or a combination of these approaches.

Fungal DNA refers to the genetic material present in fungi, which are a group of eukaryotic organisms that include microorganisms such as yeasts and molds, as well as larger organisms like mushrooms. The DNA of fungi, like that of all living organisms, is made up of nucleotides that are arranged in a double helix structure.

Fungal DNA contains the genetic information necessary for the growth, development, and reproduction of fungi. This includes the instructions for making proteins, which are essential for the structure and function of cells, as well as other important molecules such as enzymes and nucleic acids.

Studying fungal DNA can provide valuable insights into the biology and evolution of fungi, as well as their potential uses in medicine, agriculture, and industry. For example, researchers have used genetic engineering techniques to modify the DNA of fungi to produce drugs, biofuels, and other useful products. Additionally, understanding the genetic makeup of pathogenic fungi can help scientists develop new strategies for preventing and treating fungal infections.

Disk diffusion antimicrobial susceptibility tests, also known as Kirby-Bauer tests, are laboratory methods used to determine the effectiveness of antibiotics against a specific bacterial strain. This test provides a simple and standardized way to estimate the susceptibility or resistance of a microorganism to various antibiotics.

In this method, a standardized inoculum of the bacterial suspension is spread evenly on the surface of an agar plate. Antibiotic-impregnated paper disks are then placed on the agar surface, allowing the diffusion of the antibiotic into the agar. After incubation, the zone of inhibition surrounding each disk is measured. The size of the zone of inhibition correlates with the susceptibility or resistance of the bacterial strain to that specific antibiotic.

The results are interpreted based on predefined criteria established by organizations such as the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST). These interpretive criteria help categorize the susceptibility of the bacterial strain into one of three categories: susceptible, intermediate, or resistant.

It is important to note that disk diffusion tests have limitations and may not always accurately predict clinical outcomes. However, they remain a valuable tool in guiding empirical antibiotic therapy and monitoring antimicrobial resistance trends.

An immunoassay is a biochemical test that measures the presence or concentration of a specific protein, antibody, or antigen in a sample using the principles of antibody-antigen reactions. It is commonly used in clinical laboratories to diagnose and monitor various medical conditions such as infections, hormonal disorders, allergies, and cancer.

Immunoassays typically involve the use of labeled reagents, such as enzymes, radioisotopes, or fluorescent dyes, that bind specifically to the target molecule. The amount of label detected is proportional to the concentration of the target molecule in the sample, allowing for quantitative analysis.

There are several types of immunoassays, including enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), fluorescence immunoassay (FIA), and chemiluminescent immunoassay (CLIA). Each type has its own advantages and limitations, depending on the sensitivity, specificity, and throughput required for a particular application.

The most common type, also known as candidemia, candedemia, or systemic candidiasis, is caused by Candida species; candidemia ... Blood cultures should be obtained in all patients with suspected candidemia. Neutropenic vs non-neutropenic candidemia is ... The gold standard for the diagnosis of invasive candidiasis and candidemia is a positive culture. ... specifically candidemia. Oral or intravenous fluconazole is an acceptable alternative. The lipid formulation amphotericin B is ...
Most had persistent candidemia and a high mortality rate was observed. All isolates were of the same clonal strain, however, ... June 2017). "Candida auris candidaemia in Indian ICUs: analysis of risk factors". The Journal of Antimicrobial Chemotherapy. 72 ... February 2015). "Incidence, characteristics and outcome of ICU-acquired candidemia in India". Intensive Care Medicine. 41 (2): ... "Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India". Genome Announcements ...
Candidemia is a worldwide bloodstream disease mainly affecting peripheral organs in humans. Usually, candidemia caused by C. ... According to the data obtained from 2010, frequency of candidemia is 12-25% in the US, 4.5-9% in Europe, 20-24% in Brazil and ... gastrointestinal candidiasis and candidemia. C. tropicalis colonization is favoured in the gastrointestinal tract; a common ...
"Emergence of Candida parapsilosis as the Predominant Species Causing Candidemia in Children". Clinical Infectious Diseases. 26 ...
This species has been associated with candidemia and has been recovered from catheters. It has also found in biofilms on other ...
October 2007). "Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis". Clinical ... Micafungin is indicated for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis, abscesses and ... is an echinocandin antifungal medication used to treat and prevent invasive fungal infections including candidemia, abscesses, ...
Garbino, J; Kolarova, L; Rohner, P; Lew, D; Pichna, P; Pittet, D (2002). "Secular trends of candidemia over 12 years in adult ...
Although Candida albicans is the most common cause of candidemia, there has been a decrease in the incidence and an increased ... Rentz AM, Halpern MT, Bowden R (October 1998). "The impact of candidemia on length of hospital stay, outcome, and overall cost ... October 2005). "Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors ... a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia ...
Candidemia and other forms of invasive Candida infections (intra-abdominal abscess and peritonitis) Esophageal candidiasis ... "Vicuron Pharmaceuticals Files New Drug Application (NDA) for Anidulafungin for Treatment of Invasive Candidiasis/Candidemia". ... dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia". Antimicrobial ...
ISBN 978-1-55581-539-4. Weinberger, M (2016-04-16). "Characteristics of candidaemia with Candida-albicans compared with non- ...
... candidaemia, and coccidioidomycosis. Fosmanogepix is a prodrug and is converted into the active drug form, manogepix, after ...
... candidemia). C. auris has been more recently identified. Yeasts are able to grow in foods with a low pH (5.0 or lower) and in ...
The STRIVE Trial (phase 2) showed weekly treatment with Rezafungin was safe and efficacious in the treatment of candidemia and/ ... Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive ...
However, there has been a marked increase in the number of recognized cases of candidemia due to this organism in the last two ...
... candidaemia). This is almost always restricted to those with compromised immune systems, such as patients undergoing ...
... comparison of results from a reference centre and from a population-based surveillance study of candidemia". Medical Mycology. ...
... was approved by the Food and Drug Administration in March 2023 for the treatment of candidemia and invasive ...
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidemia. Nature Communic, 2014, 5:4675 ( ...
Systemic infections of the bloodstream and major organs (candidemia or invasive candidiasis), particularly in patients with an ... candidemia). Yet, there is an increasing incidence of infections caused by C. glabrata and C. rugosa, which could be because ...
Candidemia), especially prevalent in immunocompromised patients. Candida glabrata is of special relevance in nosocomial ...
... a fungemia called candidemia. Symptoms of esophageal candidiasis include difficulty swallowing, painful swallowing, abdominal ... caused by Candida Systemic candidiasis Candidemia, a form of fungemia which may lead to sepsis Invasive candidiasis ( ...
Candida oesophagitis and candidaemia. Higher minimum inhibitory concentration (MIC) of these agents has been observed against C ... the FDA approval includes indication for the treatment of candidemia and some specific Candida infections (intra-abdominal ...
... (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia ...
Investigational Drugs with Clinical Trials for: Candidemia. ⮩ Send this page by email. ✉ Email this page to a colleague ...
During a 3-year period from 1998 to 2000, there were 53 cases of candidaemia. Candida albicans (64.2 %) was the most common ... Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. 1989; Risk factors for hospital-acquired candidemia.A matched ... Bross J., Talbot G. H., Maislin G., Hurwitz S., Strom B. L. 1989; Risk factors for nosocomial candidemia: a case-control study ... Wey S. B., Mori M., Pfaller M. A., Woolson R. F., Wenzel R. P. 1988; Hospital-acquired candidemia.The attributable mortality ...
Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their incidence is increasing because of ...
Candidemia Candida species Candida non-albicans Incidence Candidemia Espécies de Candida Candida não-albicans Incidência ... The incidence of candidemia was higher than that observed in a Brazilian multicenter study. Candidemia was caused predominantly ... A incidência de candidemia foi mais alta que aquela observada em estudo multicêntrico brasileiro. Candidemia foi ... Foram observados 21 episódios de candidemia em 18 pacientes. A taxa de incidência de candidemia foi de 3,9 episódios por 1.000 ...
More than one-third of candidemia episodes occur in Internal Medicine Wards (IMWs) but only few studies have focused on this ... Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy. ...
C. albicans has historically been the most frequent cause of candidemia. However, the frequency of candidemia due to non- ... Candidemia is the isolation of Candida from one or more blood specimens. While it is more convincing to have two or more ... When candidemia is detected, it is also helpful to consider it in the context of one of the four overlapping forms of invasive ... Candidemia has become one of the most important nosocomial infections over the last two decades. An increment in its frequency ...
Candidemia is associated with a suppressed immune status and research has provided evidence that patients with candidemia might ... Condition/Disease studied: Candidemia. Keywords: invasive candidiasis; candidemia; recombinant interferon gamma 1b ... HDM-FUN-Candidemia. Ongoing study. Official Study Title. Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b ... Given With Standard Therapy in Patients With Candidemia: The HDM-FUN-Candidemia trial ...
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic ...
... with candidemia at tertiary care centers in the United States in parallel with a candidemia treatment trial that included ... 46%; P,.001). Mortality was similar among subjects with Candida glabrata or non-glabrata candidemia; mortality was also similar ... In adults, Candida parapsilosis fungemia was associated with lower mortality than was non-parapsilosis candidemia (24% vs. ... A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and ...
Na, S. K., Park, K. J., Kim, H. J., & Lee, S. C. (1997). Hematogenous endophthalmitis in a patient with candidemia. The Korean ... Na, SK, Park, KJ, Kim, HJ & Lee, SC 1997, Hematogenous endophthalmitis in a patient with candidemia., The Korean journal of ... Hematogenous endophthalmitis in a patient with candidemia. / Na, S. K.; Park, K. J.; Kim, H. J. et al. In: The Korean journal ... Hematogenous endophthalmitis in a patient with candidemia. In: The Korean journal of internal medicine. 1997 ; Vol. 12, No. 2. ...
Read our case study about a patient with risk factors for candidemia & how the T2Candida Panel help improve his treatment. ... New-onset suspected sepsis in a patient with risk factors for candidemia ...
Treatment Of Candidemia And Other Candida Infections. CANCIDAS is indicated for the treatment of candidemia and the following ... Most candidemia and other Candida infections were caused by C. albicans (35%), followed by C. parapsilosis (22%), C. tropicalis ... Most candidemia infections were caused by C. albicans (39%), followed by C. parapsilosis (20%), C. tropicalis (17%), C. ... Table 3: Adverse Reactions Among Patients with Candidemia or Other Candida Infections*. Incidence 10% or Greater for at Least ...
In patients with candidemia admitted to medical or surgical wards, clinical severity but not the initial antifungal strategy ... Initial antifungal strategy does not correlate with mortality in patients with candidemia. Murri, Rita;Scoppettuolo, Giancarlo; ... In patients with candidemia admitted to medical or surgical wards, clinical severity but not the initial antifungal strategy ... The cumulative mortality 30 days after the candidemia episode was 30.8 % and was similar among groups. In the Cox regression ...
Acute Pyelonephritis and Candidemia Due to Candida lusitaniae: A Case Report. Motoyuki Tsuboi, Shunsuke Uno, Ryota Hase, Yudai ... Acute Pyelonephritis and Candidemia Due to Candida lusitaniae: A Case Report. / Tsuboi, Motoyuki; Uno, Shunsuke; Hase, Ryota et ... Acute Pyelonephritis and Candidemia Due to Candida lusitaniae: A Case Report. Kansenshōgaku zasshi. The Journal of the Japanese ... Acute Pyelonephritis and Candidemia Due to Candida lusitaniae : A Case Report. In: Kansenshōgaku zasshi. The Journal of the ...
Time to blood culture positivity as a marker for catheter-related candidemia.. ... Time to blood culture positivity as a marker for catheter-related candidemia. J Clin Microbiol. 2008 Jul; 46(7):2222-6. ...
Investigators reviewed cases of candidemia and compared outcomes in patients with candidemia both before and after the ... SAN DIEGO - The use of the diagnostic T2Candida (T2C) panel for the identification of candidemia has resulted in a significant ... From 2015 to 2016, investigators found a significant decrease in the TTT in all patients with candidemia who had a positive ... The T2Candida Panel Has Decreased Time to Therapy Initiation for Candidemia. Brandon May ...
Results: Patients with candidemia (n = 213) were enrolled. Adherence to all five elements was achieved in 36 cases (16.9%), ... Results: Patients with candidemia (n = 213) were enrolled. Adherence to all five elements was achieved in 36 cases (16.9%), ... Results: Patients with candidemia (n = 213) were enrolled. Adherence to all five elements was achieved in 36 cases (16.9%), ... Results: Patients with candidemia (n = 213) were enrolled. Adherence to all five elements was achieved in 36 cases (16.9%), ...
Candidemia. *Multidrug-resistant Acinetobacter baumannii. *Carbapenem-resistant Enterobacterales (CRE). What is OHA doing to ...
Candida bloodstream infections (Candidemia) [PDF - 5 Pages]. *Clostridioides difficile infections [PDF - 3 Pages] ...
Disposition in Candidemia and Other Candida Infections (Intra-abdominal abscesses, peritonitis, and pleural space infections) ... Patients with Candidemia or other Candida Infections ** Incidence ,/=2% for at least one treatment group by Body System ... Most candidemia infections were caused by C. albicans (39%), followed by C. parapsilosis (20%), C. tropicalis (17%), C. ... Patients with Candidemia or other Candida Infections ** Incidence ,/=2% for at least one treatment group by Laboratory Test ...
The objective of this study is to evaluate the prevalence of candidemia in patients with risk factors as per the 2009 ... Methods: This is a single-centered, retrospective chart review of all inpatients with a diagnosis of candidemia, treated with ... On average, moderate to severely ill patients had a higher prevalence of candidemia. The most prevalent isolates were Candida ... A laboratory department generated blood culture report will be used to identify candidemia patients. All patients under the age ...
... candidemia (1 case); wound infection with Clostridium perfringens (1 case); Mycoplasma arthritis (1 case); and other infections ...
1.2 Candidemia in Non-neutropenic Patients and Other Deep Tissue Candida Infections 1.3 Scedosporiosis and Fusariosis 1.4 Usage ... 14.2 Candidemia in Non-neutropenic Patients and Other Deep Tissue Candida Infections 14.3 Other Serious Fungal Pathogens 14.4 ... Candidemia in non-neutropenic patients and other deep tissue Candida infections See Table 1. Patients should be treated for at ... Most of the candidemia in patients evaluated for efficacy was caused by C. albicans (46%), followed by C. tropicalis (19%), C. ...
Clostridium difficile Coinfection Among Patients With Candidemia. Clin Infect Dis. 2019 Feb 1;68(4):676-679. doi: 10.1093/cid/ ...
Candidemia (25 drugs) Legend. Rating. For ratings, users were asked how effective they found the medicine while considering ...
Candidemia Therapeutic Assessment: Candidemia current marketed and Candidemia emerging therapies. *Candidemia Market Dynamics: ... Candidemia market report covers a descriptive overview and comprehensive insight of the Candidemia Epidemiology and Candidemia ... Candidemia Market The dynamics of the Candidemia market are anticipated to change in the coming years owing to the expected ... Some of the key facts of the Candidemia Market Report: *The Candidemia market size is anticipated to grow with a significant ...
The most common type, also known as candidemia, candedemia, or systemic candidiasis, is caused by Candida species; candidemia ... Blood cultures should be obtained in all patients with suspected candidemia. Neutropenic vs non-neutropenic candidemia is ... The gold standard for the diagnosis of invasive candidiasis and candidemia is a positive culture. ... specifically candidemia. Oral or intravenous fluconazole is an acceptable alternative. The lipid formulation amphotericin B is ...
Candidemia in thoracic solid organ transplant recipients: Characteristics and outcomes rel Candidemia in thoracic solid organ ... Candidemia; Transplante de Coração; Transplante de Pulmão; Transplante de Órgãos; Humanos; Candidemia/etiologia; Estudos ... Twenty-one (5.5%) heart and six (3.1%) lung recipients developed candidemia. Heart recipients with candidemia were more likely ... Candidemia following heart and lung transplantation is associated with significant morbidity and mortality. Further research is ...
Three patients developed candidemia; they had CI ≥0.5 before infection. Positive values of Candida mannan antigen and anti- ... mannan antibodies were found only in the patients with candidemia. The sensitivity and specificity of the Candida mannan test ...
  • At least one blood culture obtained by peripheral vein puncture that grew Candida species was defined as candidemia. (biomedcentral.com)
  • 5 days starting from the first culture result indicated positive for Candida , the infection was considered persistent candidemia. (biomedcentral.com)
  • Cases of candidemia were defined as occurrences of isolation of Candida spp from blood cultures. (unifesp.br)
  • Um caso de candidemia foi definido como isolamento de Candida spp de hemocultura. (unifesp.br)
  • Candidemia is the isolation of Candida from one or more blood specimens. (drfungus.org)
  • However, the frequency of candidemia due to non- albicans species of Candida rose during the 1990s [ 4 , 1641 , 1846 , 2444 , 2445 ] and recent surveys find that C. albicans causes only about half of all cases of candidemia [ 1717 , 1779 ]. (drfungus.org)
  • Ascending pyelonephritis and candidemia due to Candida species are uncommon complications. (elsevierpure.com)
  • We diagnosed acute pyelonephritis and candidemia due to Candida species and started treatment with fluconazole. (elsevierpure.com)
  • In patients who were treated empirically or who had candidemia or other Candida infections (intra-abdominal abscesses, peritonitis, or pleural space infections), a similar modest effect of age was seen in older patients relative to younger patients. (theodora.com)
  • Candidemia is a medical condition characterized by the presence of Candida species, particularly Candida albicans, in the bloodstream. (michigannewsupdates.com)
  • We assessed whether the time to detection of Candida species in peripheral blood (time to positivity [TTP]) can serve as a marker for catheter-related candidemia. (wustl.edu)
  • Candida tropicalis is the fourth main infective agent of Candida species in several developing nations and leads to the greatest fatality rate among the non-albicans Candida (NAC) species that cause candidemia. (microbiologyjournal.org)
  • Candida species causing bloodstream infections (BSIs) are also called candidemia which exists mostly as a pervasive type of invasive candidiasis. (microbiologyjournal.org)
  • 2 C. tropicalis is the fourth main infective agent of Candida species in several developing nations and contributes the greatest fatality rate among the NAC species that cause candidemia. (microbiologyjournal.org)
  • Candidemia, which is the bloodstream manifestation of fungal infections due to Candida , turns out in recent studies that we've looked at are the most common if not some of the most common healthcare associated bloodstream infections in our country, in the United States. (cdc.gov)
  • Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. (ssi.dk)
  • 6 - 8 This antifungal class shows excellent in vitro and in vivo activity against Candida species and has quickly become the first therapeutic choice for the treatment of candidemia and other forms of invasive Candida infections. (dovepress.com)
  • So, candidemia are bloodstream infections that are due to the fungus candida. (cdc.gov)
  • Candidemia accounted for 8% of all hospital-acquired bloodstream infections, and Candida species were the fourth most common cause of septicemia. (cdc.gov)
  • Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their incidence is increasing because of the growing complexity of patients. (efim.org)
  • The best evidence regarding the anti-fungal treatment for invasive candidiasis comes from randomized controlled trials in which more than 85% of the recruited patients had candidemia. (efim.org)
  • When candidemia is detected, it is also helpful to consider it in the context of one of the four overlapping forms of invasive candidiasis . (drfungus.org)
  • The gold standard for the diagnosis of invasive candidiasis and candidemia is a positive culture. (wikipedia.org)
  • Rezafungin was approved by the Antimicrobial Drugs Advisory Committee of the US Food and Drug Administration (FDA) to treat candidemia and invasive candidiasis in adult patients by a vote of 14 to 1 . (newshawkonline.com)
  • In fact, the true burden of invasive candidiasis might be twice as high as the estimate for candidemia," Profounda said in a press statement announcing the new orphan drug designation. (medscape.com)
  • In July, Cidara presented new analyses from multiple studies of rezafungin for the treatment of candidemia and invasive candidiasis and prevention of invasive fungal infections at ECCMID. (biospace.com)
  • Three additional posters at ECCMID highlighted areas of unmet need to improve treatment of candidemia and invasive candidiasis. (biospace.com)
  • Candidemia is among the most common causes of nosocomial bloodstream infections in U.S. patients. (baptisthealth.net)
  • candidemia is also among the most common bloodstream infections of any kind. (wikipedia.org)
  • Candidemia is a serious, life-threatening bloodstream infection and possibly the fourth most common all-type bloodstream infections seen in the intensive care unit setting. (newshawkonline.com)
  • This condition includes the potentially life-threatening candidemia, which is among the most common bloodstream infections in hospitalized patients in the United States. (medscape.com)
  • This study aimed to investigate the epidemiology of persistent candidemia over a 4-year period in a neonatal intensive care unit (NICU) in Liuzhou, China. (biomedcentral.com)
  • Risk factors for candidemia in neonatal intensive care unit patients.The National Epidemiology of Mycosis Survey study group. (microbiologyresearch.org)
  • More than one-third of candidemia episodes occur in Internal Medicine Wards (IMWs) but only few studies have focused on this setting and specific data about epidemiology, clinical characteristics and risk factors for mortality are scant. (efim.org)
  • A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. (qxmd.com)
  • The Candidemia epidemiology section provides insights into the historical and current Candidemia patient pool and forecasted trends for seven individual major countries. (michigannewsupdates.com)
  • Candidemia market report covers a descriptive overview and comprehensive insight of the Candidemia Epidemiology and Candidemia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan. (newshawkonline.com)
  • Time to blood culture positivity as a marker for catheter-related candidemia. (ucdenver.edu)
  • We conclude that TTP in peripheral blood is a sensitive but nonspecific marker for catheter-related candidemia and that a TTP of more than 30 h can help exclude an intravascular catheter as the possible source of candidemia. (wustl.edu)
  • 4 patients with candidemia who had tion with molecular techniques will 4. (cdc.gov)
  • Twenty-one episodes of candidemia were observed in 18 patients. (unifesp.br)
  • Given the high mortality and morbidity of candidemia, a recent international consensus conference concluded that essentially all patients with candidemia should receive therapy [ 649 ]. (drfungus.org)
  • The use of fluconazole in prophylactic regimens for severely immunosuppressed patients has been strongly associated with the changes in the etiology of candidemia in this population [ 4 , 2444 , 2445 ]. (drfungus.org)
  • Candidemia is associated with a suppressed immune status and research has provided evidence that patients with candidemia might benefit from recombinant interferon gamma (rIFN-γ) immunotherapy. (sepsis.gr)
  • This study aims to assess the safety and efficacy of adjunctive rIFN-γ treatment to standard antifungal therapy on outcome in patients with candidemia. (sepsis.gr)
  • During the study period, 130 patients with candidemia were observed (58 % with C. albicans, 7 % with C. glabrata, and 23 % with C. parapsilosis). (unicatt.it)
  • No differences in 15-day and 30-day mortality were observed between patients with and without C. albicans candidemia. (unicatt.it)
  • In patients with candidemia admitted to medical or surgical wards, clinical severity but not the initial antifungal strategy were significantly correlated with mortality. (unicatt.it)
  • Investigators reviewed cases of candidemia and compared outcomes in patients with candidemia both before and after the initiation of regular T2C testing. (infectiousdiseaseadvisor.com)
  • In this analysis, researchers included 100 and 138 patients with candidemia during the 2015 and 2016, respectively. (infectiousdiseaseadvisor.com)
  • Results: Patients with candidemia (n = 213) were enrolled. (unicatt.it)
  • Conclusions: Five elements, including therapeutic and non-therapeutic-related aspects, of care were good indicators of appropriate management of patients with candidemia. (unicatt.it)
  • The objective of this study is to evaluate the prevalence of candidemia in patients with risk factors as per the 2009 Infectious Diseases Society of America (IDSA) guidelines, to assess the appropriateness of therapy in patients with candidemia, and to compare the cost of fluconazole versus micafungin at initiation of therapy in our institution. (baptisthealth.net)
  • A laboratory department generated blood culture report will be used to identify candidemia patients. (baptisthealth.net)
  • On average, moderate to severely ill patients had a higher prevalence of candidemia. (baptisthealth.net)
  • Blood cultures should be obtained in all patients with suspected candidemia. (wikipedia.org)
  • Around 80% of patients with candidemia have an indwelling central venous catheter (CVC). (wustl.edu)
  • Thirteen patients (20.3%) had definite catheter-related candidemia. (wustl.edu)
  • 1 Candidemia is one of the most prevalent reasons for BSIs among hospitalized patients in the United States, and it frequently leads to prolonged hospitalization as well as mortality. (microbiologyjournal.org)
  • Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. (thieme-connect.de)
  • Des analyses régulières de la résistance aux antifongiques dans les centres médicaux sont fortement recommandées, car les résultats permettront une prise en charge plus efficace de la candidose systémique chez les patients immunodéprimés. (who.int)
  • The use of central venous catheters (CVC) and broad-spectrum antibacterials are among the main risk factors for the development of candidemia in patients admitted to intensive care units (ICU). (bvsalud.org)
  • These results suggest that increased candidemia in ICU patients is not attributable to possible alterations in the yeasts, but is more likely caused by a weakening of the patient's general condition after long exposure to infection. (bvsalud.org)
  • Although VLBW is a well-known risk factor in the development of candidemia, it is uncertain whether this risk factor also contributes to persistent candidemia or mortality. (biomedcentral.com)
  • Only a few studies have evaluated the risk factors and mortality for persistent candidemia in VLBW infants, and the results remain controversial. (biomedcentral.com)
  • The potential risk factors and attributable mortality of persistent candidemia in VLBW infants in Western China are unknown. (biomedcentral.com)
  • Therefore, we conducted this study to identify the incidence, risk factors, microbiological results and mortality associated with persistent candidemia in VLBW infants in China. (biomedcentral.com)
  • Hospital-acquired candidemia.The attributable mortality and excess length of stay. (microbiologyresearch.org)
  • This idea was gradually reversed by reports showing that candidemia was associated with significant morbidity and mortality. (drfungus.org)
  • mortality was also similar among subjects with C. glabrata candidemia who received fluconazole rather than other antifungal therapy. (qxmd.com)
  • The cumulative mortality 30 days after the candidemia episode was 30.8 % and was similar among groups. (unicatt.it)
  • Objectives: Taking into account the significant morbidity, mortality, and hospital costs related to Candidemia, our objective is to define if improving appropriateness in candidemia management was associated with better clinical outcomes. (unicatt.it)
  • Candidemia following heart and lung transplantation is associated with significant morbidity and mortality . (bvsalud.org)
  • Lack of specific signs or symptoms in the development of candidemia among VLBW infants results were in a high risk of fatality [ 8 ]. (biomedcentral.com)
  • This is a single-centered, retrospective chart review of all inpatients with a diagnosis of candidemia, treated with either fluconazole or micafungin, from January 2010 to December 2014, and approved by our health care system's Institutional Review Board. (baptisthealth.net)
  • C. tropicalis is considered the first and most predominant species causing candidemia in growing nations, wherein an enormous number of cases are treated by Fluconazole as a consequence of the outrageous price of echinocandins. (microbiologyjournal.org)
  • Heart and lung recipients who developed candidemia were more likely to have been on renal replacement therapy prior to infection relative to uninfected controls (57.1% vs. 11.9%, p = .0003 and 66.7% vs. 0%, p = .0041, respectively). (bvsalud.org)
  • Heart recipients with candidemia had significantly lower post- transplant survival and lower post- infection survival relative to matched uninfected controls and heart recipients with bacteremia , respectively (p (bvsalud.org)
  • Candidemia is a serious infection of the bloodstream. (merckmanuals.com)
  • Cidara's oral presentation reviewed a new sub-analysis from the STRIVE Phase 2 trial demonstrating clearance of infection in the initial days of treatment of candidemia following one dose of rezafungin, compared to multiple doses of the standard of care. (biospace.com)
  • The source of infection for candidaemia is predominantly the patient's own colonising flora (mainly GI tract or skin). (futurelearn.com)
  • Voriconazole is used in adults and children 2 years of age and older to treat serious fungal infections such as invasive aspergillosis (a fungal infection that begins in the lungs and spreads through the bloodstream to other organs), esophageal candidiasis (a yeast [a type of fungus] infection that may cause white patching in the mouth and throat), and candidemia (a fungal infection in the blood). (medlineplus.gov)
  • We conducted a prospective, observational, laboratory-based study on candidemia to investigate the incidence of candidemia, species distribution and clinical conditions between September 2003 and March 2004 in a private tertiary hospital in Recife, northeastern Brazil. (unifesp.br)
  • Candidemia was caused predominantly by non-albicans species. (unifesp.br)
  • The incidence of candidemia was higher than that observed in a Brazilian multicenter study. (unifesp.br)
  • We conducted a prospective, multicenter observational study of adults (n=1447) and children (n=144) with candidemia at tertiary care centers in the United States in parallel with a candidemia treatment trial that included nonneutropenic adults. (qxmd.com)
  • The incidence of candidemia in tertiary public Material hospitals in Brazil is approximately 2.5 cases per 1000 hospital admissions (Colombo et al . (bvsalud.org)
  • SAN DIEGO - The use of the diagnostic T2Candida (T2C) panel for the identification of candidemia has resulted in a significant decrease in time to initiation of therapy (TTT) and may usher in more rapid and optimal utilization of antifungal therapy in the c patient population, according to findings from a retrospective study presented at IDWeek 2017 . (infectiousdiseaseadvisor.com)
  • These results suggest that rapid identification of candidemia may be an important tool for [antifungal therapy] stewardship. (infectiousdiseaseadvisor.com)
  • 6 As stated by the Centers for Disease Control and Prevention (CDC), around 25,000 candidemia incidences were reported nationwide each year. (microbiologyjournal.org)
  • An estimated 25,000 cases of candidemia occur nationwide each year, according to the Centers for Disease Control and Prevention (CDC). (medscape.com)
  • The incidence rate of candidemia was 3.9 episodes per 1,000 admissions. (unifesp.br)
  • Among EU4 and the UK, it was observed that Spain had the highest incidence rate of Candidemia. (michigannewsupdates.com)
  • The clinical manifestations of candidemia range from nothing more than fever to overt and life-threatening sepsis. (drfungus.org)
  • Brazil, Peru) ( 3 , 7 , 8 ) and 1 in Africa agent of candidemia in South Africa, (Ethiopia) ( 9 ). (cdc.gov)
  • We retrospectively extracted demographic data, risk factors, microbiological results and outcomes of very low birth weight infants with candidemia in our hospital between January 2012 and November 2015. (biomedcentral.com)
  • Candidemia in thoracic solid organ transplant recipients: Characteristics and outcomes relative to matched uninfected and bacteremic thoracic organ transplant recipients. (bvsalud.org)
  • Little is understood about the risk factors and outcomes from candidemia in thoracic solid organ transplant recipients. (bvsalud.org)
  • The Candidemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Candidemia market size from 2019 to 2032, segmented by seven major markets. (michigannewsupdates.com)
  • According to DelveInsight, the Candidemia market in 7MM is expected to witness a major change in the study period 2019-2032. (michigannewsupdates.com)
  • The dynamics of the Candidemia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. (newshawkonline.com)
  • Foram observados 21 episódios de candidemia em 18 pacientes. (unifesp.br)
  • We performed two comparisons among heart and lung transplant recipients (1) recipients with candidemia versus matched, uninfected recipients, and (2) recipients with candidemia versus recipients with bacteremia . (bvsalud.org)
  • The purpose of this study was to determine if the introduction of real-time pharmacist response to positive rapid diagnostic test results would decrease time to antimicrobial therapy for gram-positive bacteremia and candidemia in a community hospital setting. (houstonmethodist.org)
  • Candidemia foi predominantemente causada por espécies não-albicans. (unifesp.br)
  • C. albicans has historically been the most frequent cause of candidemia. (drfungus.org)
  • This study highlights the importance of intensive prevention and effective treatment among neonates with persistent candidemia. (biomedcentral.com)
  • Thus, it cannot be disputed that there are individual cases where candidemia resolves satisfactorily without treatment [ 664 , 762 ]. (drfungus.org)
  • Treatment of candidemia has two fundamental elements. (drfungus.org)
  • Evaluation of candidemia prevalence and treatment cost comparison in a" by Bertha P. Rojas, Claudia Chang et al. (baptisthealth.net)
  • The Report also covers current Candidemia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Candidemia market. (michigannewsupdates.com)
  • Learn more about Candidemia treatment algorithms in different geographies, and patient journeys. (michigannewsupdates.com)
  • The extensive utilization of antifungal agents increases C.tropicalis antifungal resistance, especially to azoles, which would ultimately result in the treatment failure of candidemia. (microbiologyjournal.org)
  • ISAVUCONAZOLE (BAL8557) drug's evaluation in the Phase III trial was completed for the treatment of candidemia in 2015, after which there is no update of the drug for Candidemia treatment. (newshawkonline.com)
  • An intravenous echinocandin such as anidulafungin, caspofungin or micafungin is recommended as first-line therapy for fungemia, specifically candidemia. (wikipedia.org)
  • Candidemia typically occurs in individuals with weakened immune systems, such as those with HIV/AIDS, undergoing chemotherapy, or receiving immunosuppressive therapy. (michigannewsupdates.com)
  • Sixty-four candidemia episodes were included. (wustl.edu)
  • Realizou-se um estudo observacional, prospectivo, de base laboratorial, para investigar a incidência de candidemia, distribuição de espécies e condições clínicas entre setembro 2003 e março 2004, em um hospital privado terciário em Recife, Nordeste do Brasil. (unifesp.br)
  • A incidência de candidemia foi mais alta que aquela observada em estudo multicêntrico brasileiro. (unifesp.br)
  • Other than that, the risk factors for HIV-infected individuals who develop candidemia are similar to those in non-HIV-infected individuals: central venous catheters, parenteral nutrition, and previous use of broad spectrum antibiotics. (drfungus.org)
  • The reader is referred to our discussion of intravascular catheters and candidemia . (drfungus.org)
  • The prevalence of candidemia in our facility was predominately attributed to the use of implantable prosthetic devices, broad-spectrum antibiotics, and central venous catheters. (baptisthealth.net)
  • The Candidemia market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Candidemia market trends by analyzing the impact of current Candidemia therapies on the market and unmet needs, and drivers, barriers, and demand for better technology. (michigannewsupdates.com)
  • The Candidemia market report provides insights on the current and emerging therapies. (newshawkonline.com)
  • Sarah Gregory] Your article specifically discusses candidemia infections associated with intravenous drug use. (cdc.gov)
  • Candidemia market report provides a global historical and forecasted market covering drug outreach in 7MM. (newshawkonline.com)
  • The Candidemia diagnosed incident population in the 7MM countries was estimated to be approximately 41,000+ cases in 2022, with the United States contributing approximately 23,000+ cases. (michigannewsupdates.com)
  • Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. (microbiologyresearch.org)
  • Risk factors for hospital-acquired candidemia.A matched case-control study. (microbiologyresearch.org)
  • Isolated case reports and a single retrospective study have been published on candidemia in HIV-infected adults [ 1282 , 1303 , 2263 ]. (drfungus.org)
  • During a 3-year period from 1998 to 2000, there were 53 cases of candidaemia. (microbiologyresearch.org)
  • C. tropicalis (38%) is the commonest organism in India among candidemia cases. (microbiologyjournal.org)
  • However, at the beginning of this decade, we began to see cases of candidemia. (cdc.gov)
  • What she found was that there were a 198 such cases of candidemia in the hospital. (cdc.gov)
  • The Candidemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. (newshawkonline.com)
  • A total of 354 valid T2C results were reported in 2016, of which 36 (10.2%) were positive and 318 (89.8%) were negative for candidemia. (infectiousdiseaseadvisor.com)
  • Both mechanical ventilation and intubation were significantly associated with increased rates of persistent candidemia ( P = 0.044 and 0.004, respectively). (biomedcentral.com)
  • Furthermore, launching various multiple-stage Candidemia pipeline products will significantly revolutionize the Candidemia market dynamics. (newshawkonline.com)
  • Symptoms of candidemia may include fever, chills, rapid heart rate, low blood pressure, and sometimes skin rashes or lesions. (michigannewsupdates.com)